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Investigation of the radioprotective effect of arbutin 
on radiation-induced lung injury in rats: a 
histopathological study 
INTRODUCTION 
Radiotherapy is known as one of the main 
non-surgical options for treating the                          
malignancies (1). Despite recent advances in          
radiotherapy techniques, there is still                          
risk of damage to healthy tissues (2, 3).                                   
Radiotherapy-induced side effects can be              
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ABSTRACT 
Background: Radiation-induced lung injury is a common complication after 
esophageal, breast, etc. cancer radiotherapy. We aimed to evaluate the 
radioprotective effect of arbutin on acute radiation-induced lung damage in 
male rats. Materials and Methods: Fifty-two male Wistar rats were divided 
into 4 groups: (i) control group (n = 10), (ii) vehicle group (n = 10, received 
distilled water intraperitoneally (ip)), (iii) X-irradiation only (n=16, chest was 
irradiated to a single dose of 20 Gy x-rays) and (iv) arbutin + X-irradiation 
(n=16, 75 mg/kg of arbutin 2 hours before irradiation (ip), and then their 
chest was exposed to 20 Gy x-rays). For histopathological investigation, 8 
animals of each group were sacrificed 8 weeks after treatment and the rest of 
them were sacrificed 3 months after treatment. Results: The histopathological 
analysis in 8 weeks after X-irradiation showed that there was a significant 
increase in inflammatory in X-irradiation only group compared to control 
group. The administration of arbutin 2 hours prior to X-irradiation significantly 
reduced inflammation and inflammatory factors such as macrophages, mast 
cell and neutrophil in arbutin + X-irradiation group compared to X-irradiation 
only group (P<0.05). The histopathologic investigation performed 3 months 
after lung irradiation indicated a significant reduction in fibrosis formation in 
arbutin + X-irradiation group compared to irradiation only group (P<0.05). 
Localized chest X-irradiation with 20 Gy caused histopathologic damage to the 
lungs for short -term. Conclusion: Arbutin has a great potential in reducing 
the histopathologic damage to lung tissue after thoracic irradiation.  
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divided into two categories: early (acute) and 
late radiation toxicity. Early effects occur during 
or within a few weeks after treatment, and late 
effects appear months to many years after             
exposure to radiation (4).  
In radiotherapy for esophageal cancer, breast 
cancer, and lymphatic system cancer, the lungs 
are an important organ at risks (OARs) (4, 5). On 
the other hand, Radiation-induced lung injury is 
considered as the main radiation dose-limiting 
factor in radiotherapy for lung cancer, breast 
cancer, lymphoma, etc. Radiation-induced lung 
toxicities are including pneumonia and fibrosis 
(4, 5). Pneumonia is considered as an early effect 
of radiation that involves inflammatory              
response to capillary obstruction. In addition, 
pneumonia results in inflammatory cell                       
infiltration such as neutrophils, macrophages, 
etc. into the alveolar wall and air sac. The                 
severity of pneumonia induced by radiation             
directly depends on the radiation dose. Unlike 
pneumonia, radiation fibrosis is the late                  
manifestation of radiation-induced lung injury 
and appears through the formation of collagen 
strands in alveoli wall (4, 5).   
     Arbutin (hydroquinone-β-D-glucopyranoside) 
is a hydroquinone glycoside that is found               
abundantly in the food plants, fruits, and their 
products such as wheat, broccoli, stems, pepper, 
coffee, and shrubs. Its chemical formula is 
C12H16O7 and its molecular weight is 272.25 g/
mol (6). Arbutin plays an anti-apoptotic role in 
reducing production of intracellular hydroxyl 
radicals by scavenging the free radical activity (7, 
8). It is also used as a component in skin care 
products (9). High doses of the arbutin have the 
potential to become an antitumor agent (6). It has 
been reported that arbutin inhibits proliferation 
of TCC-SUP cells in bladder cancer by regulating 
high levels of p12 (10). In addition, arbutin can 
protect the liver against oxidative damage                  
induced by carbon tetrachloride in rats (11). As 
far as we know, the impact of arbutin on                     
radiation-induced lung damage has not been  
investigated. Therefore, the purpose of this 
study was to evaluate the effect of arbutin on 
acute radiation-induced lung injury in 8 weeks 
and 3 months after X-irradiation in male rats. 
414 
MATERIALS AND METHODS 
 
Animal 
In this study, chemical materials including 
arbutin (CAS registry number: 497-76-7  ( were 
purchased from Sigma Chemical Co. (St. Louis, 
Mo, USA). Fifty-two adult male Wistar rats 
(mean weighting 220 ± 25 g, 10-12-week-old) 
were purchased from Neuroscience Research 
Center of Kerman, Iran. All rats were housed and 
maintained under specific pathogen-free              
conditions in facilities approved by National  
Institute of Health and Animal Atmosphere in 
Kerman University of Medical Sciences (KUMS), 
Kerman, Iran. These principles include                     
characteristics of animal's natural life in                    
captivity situation, using spacious cage,                      
preparing appropriate ventilation and light,  
handling with care, given standard pellet diet 
and water ad libitum, etc., taking into account 
the 12-hour standby time, temperature of 25 ± 2 
ᵒC, relative humidity of 55 ± 5 %, and usual  
feeding of animals with sufficient diet without 
any additives. The study was approved by the 
ethics committee of KUMS, Kerman, Iran. 
 
Experimental design 
Fifty-two male Wistar rats were divided into 
4 groups. Group 1 (n=10, control group) did not 
receive radiation and arbutin, group 2 (n=10, 
vehicle group) received distilled water                      
intraperitoneally (i.p), group 3 (n=16) received a 
single dose of 20 Gy X-rays, and group 4 (n=16) 
received arbutin (75 mg/kg of arbutin 2 hours 
before irradiation (i.p)), and then their chest  
areas were exposed to 20 Gy X-rays. For                     
histopathological investigation, 8 animals of 
each group were sacrificed 8 weeks after                  
treatment and the rest of them were sacrificed 3 
months after treatment.  
 
Animal exposure 
Prior to radiation exposure, all rats were 
anesthetized using Ketamine (Alphasan,                
Netherland Bv, 100 mg/kg) and Xylazine 
(Alfasan, Woerden, Holland, 0.5 mg/kg), and 
then these were placed on a transparent plate 
made of Prespex with a thickness of 1 cm. All 
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rats were immobilized in the supine position 
that positioning was facilitated by taping the  
extremities on a ventilated Prespex container. In 
all experiments, the thoracic regions of rats were 
irradiated with a 6 MV linear accelerator (Elekta 
Compact 6 MV, China) at Radiation Center of 
Shafa Hospital in Kerman, at a source-to-skin 
distance of 100 cm, with a field size of 5 × 5 cm2.  
A single dose of 20 Gy X-radiation was delivered 
to the whole chest regions at a dose rate of 350 
monitor unite (MU). In the present study, single 
dose of 20 Gy was applied based on the results 
published by Buttner et al. that showed a single 
dose of 20 Gy can develop considerable                       
radiation lung injury (12). 
Arbutin (Sigma) was dissolved in distilled 
water (pH=7) and administered i.p 2 hours              
before irradiation. To obtain optimum radiation 
protective effect of arbutin, the dose of 75 mg/kg 
was selected for present study based on the            
reports by Mirshahvalad and collegeous (11). 
They demonstrated that this dose has better 
protective effect against liver damage induced 
by carbon tetrachloride in rats (11). To prepare 
this dose, 20 mg of arbutin was dissolved in 1 ml 
of distilled water. 
 
Body weight measurement  
Body weights were assessed for 4 groups at 
different times, pre-irradiation, 20 day, 2 
months and 3 months after irradiation. Body 
weights assessed after irradiation were                   
compared to baseline weight to investigate any 




For histopathologic examination, animals 
were anesthetized with Ketamine and Xylazine 8 
weeks and 3 months after X-irradiation, and 
then chests were opened. The lung was perfused 
through right ventricle of the heart using 0.9% 
sodium chloride, Then, the lungs were separated 
and stored in formalin 10% after fixation of the 
samples in formalin and the tissue passage, 
which included insertion of samples into xylene 
and paraffin (Shimiran, Iran), respectively. The 
lungs were sliced into 5 micron thick sections 
and stained using Hematoxylin and Eosin (H & 
E) (13), Massons Trichrome (MTC) (14) and Giemsa 
(15) methods. Stained patches were investigated 
under the light microscope (Olympus BX41TF, 
Japan) by a pathologist blinded to the samples. 
In general, several factors were considered as 
indicators of pulmonary injury. Descriptive              
factors of radiation-induced pulmonary damage 
include macrophage (excessive macrophage in 
the alveolar sac), inflammation (excessive               
inflammation in alveolar sac), neutrophil 
(excessive neutrophil counts in alveolar sac and 
alveolar), Lymphocyte (excess lymphocyte in 
alveolar lobe), mast cell (presence of mast cells 
in alveolar space), erythrocyte (excessive               
erythrocyte in alveolar wall) and fibrosis (the 
presence of collagen in alveolar sac). To quantify 
the data, the above-mentioned factors are shown 
as following: no increase (one), mild increase 




Statistical analysis was performed using SPSS 
20.0 software (SPSS Inc., Chicago, IL, USA).               
Covariance analysis (ANOVA) and Tukey’s post 
hoc test were used to investigate weight                     
variation between groups. In histopathologic 
tests, Mann-Whitney Non- Parametric Bread 
Test was used and the groups were compared in 
two by two. Results were considered to be                





Body weight investigation 
There was no significant difference in body 
weight between groups before irradiation. The 
results of body weight at different follow-up 
times are shown in table 1. In the first 20 days 
after irradiation, mean body weight significantly 
reduced in the X-irradiation and arbutin +                    
X-irradiation groups while it increased in the 
control and vehicle groups (P<0.05). Beyond 2 
months follow-up, the mean body weights                
increased in the all study groups. In the third 
month, the mean body weights decreased in the 
X-irradiation and arbutin + X-irradiation groups 
while increase in average weight continued until 
Jahanbani et al. / Radioprotective effect of arbutin on radiation-induced lung injury 



































   
   




















the third month in the other two groups. At the 
end of the third month, the mean weights in                 
X-irradiation group and arbutin + X-irradiation 
group significantly decreased in comparison to 
the control group in the third month. Of note, 
there was no statistically significant difference 
(P>0.05) in average body weight between                     
X-irradiation group and arbutin + X-irradiation 
group in the third month.  
 
Histopathological examination 
Lesions and pathologic changes in lung of 
rats in 8 weeks after irradiation are outlined in 
table 2. In this period, there was a statistically 
significant difference in terms of quality                     
inflammation variables (P=0.005) and mast cell 
(P=0.003), macrophage (P=0.006), neutrophil 
(P=0.004), erythrocyte (P=0.01) lymphocyte 
with (P=0.005) between the X-irradiation group 
and control group. Meanwhile, a significant               
difference no found between X-irradiation group 
and control group for fibrosis. When the changes 
between X-irradiation group and arbutin +                   
X-irradiation group were compared, there were 
statistically significant difference regarding the 
incidence of inflammation (P=0.04) and Mast 
cell (P=0.005) and presence of macrophage 
(P=0.02) and neutrophil (P=0.02), as displayed 
in figures 1 and 2.  
Moreover, there was a significant difference 
in all qualitative variables except fibrosis                    
between the group receiving arbutin +                          
X-irradiation and the control group. Besides, a 
significant difference in inflammation,                       
macrophage, mast cell, and neutrophil was found 
between arbutin + X-irradiation and                              
X-irradiation groups. Figures 1 and 2 illustrate 
the results of lung indexes of control rats versus 
experimental rats evaluated 8 weeks after                
local-thorax irradiations. 
Table 3 summarizes the results of pathologic 
changes (lesions) in lungs of rats three months 
after irradiation, whereas histopathological 
changes are shown in figure 3 and 4. In 3 months 
follow-up, there was a statistically                 signif-
icant difference in fibrosis (P=0.007),               in-
flammation (P=0.05), macrophage (P=0.01), 
erythrocyte (P=0.04) between X-irradiation 
group and control group. As observable in table 
3, a significant difference in histopathological 
factors such as fibrosis (P=0.04) and erythrocyte 
(P=0.05) and macrophage (P=0.005) was                      
observed between X-irradiation group and               
arbutin + X-irradiation group. In addition, there 
was no significant difference in histopathological 
factors except fibrosis (P=0.02) between arbutin 
+ X-irradiation group and control group. Also, a 
significant difference was found between arbutin 
+ X-irradiation group and vehicle group for         
fibrosis variables (P=0.02).  
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Values are expressed as mean±SD. P<0.05, statistically significant when compared between groups versus a control group, or b                       
X-irradiation group, c Vehicle group. SD: Standard deviation. 
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Table1. Effect of arbutin treatment on body weight of rats exposed to x-irradiation at follow-up times. 
Group 
Body weight (gr) 
Before  
X-irradiation 
20 days after  
X-irradiation 
2 month after  
X-irradiation 
3 month after  
X-irradiation 
Control 203.5±14.3 222.5±18.1* 257.1±15.2* 322±18.1* 
Vehicle 210.5±10.3 220±14.5* 266.8±25.5* 317.8±37.9* 
X-irradiation 208±12.7 175.5±11.5*,** 229.8±18.6* 211.4±25.2** 
arbutin + X-irradiation 207.2±11.4 182.1±10.8*,** 235±14.2* 214.5±7.7** 
Values are expressed as the mean± standard deviation (SD). * statistically significant when compared to before X-irradiation. 
 Control Vehicle X-irradiation arbutin + X-irradiation 
Inflammation 1.2 ±0.44 1.8±0.44 3.5±0.83ac 2.5±0.54 abc 
Macrophage 1.2±0.44 2± 0 3.1±0.71ac 2.1±0.41 abc 
Mast cell 1.2±0.44 1.4±0.54 3.8±0.41ac 2.3±0.81 abc 
Fibrosis 1.2±0.44 1.2±0.44 2.3±0.81 1.8±0.75 
Lymphocyte 1.4±0.54 1.2±0.44 3.5±0.54ac 2.6±1.03 a 
Erythrocyte 1.6±0.54 1.8±0.83 3.1±0.75ac 2.8±0.41 ac 
Neutrophil 1.2±0.44 1.6±0.54 3.6±0.81ac 2.6±0.51 abc 
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Figure 1. Histopathologic examination and radiation damage 
in 8 weeks after irradiation. Hematoxylin and Eosin stain with 
a magnification of × 100 (capital letters) and × 400 (lower case 
letters). (A and a) X-irradiation group: Acute inflammation in 
alveolar space, thickening of alveolar wall and pulmonary 
edema with inflammatory agents are evident. (B and b)              
arbutin+ X-irradiation group: mild inflammation. (C and c) 
Vehicle group: alveolar space, bronchiole, and vascular bed 
are normal. (D and d) Control group: Alveolar space,                
bronchiole, and vascular bed are normal. 
Table 3. Effect of arbutin treatment at 3-month post-irradiation on histopathological 
factors in the lung tissue of rats. 
Figure 2. Histopathologic examination and radiation damage 
in 8 weeks after irradiation. Giemsa stain with a magnification 
of × 100 (capital letters) and × 400 (lower case letters). Mast 
cells are blue dots and the arrows indicate an accumulation of 
mast cell in lung tissue. (A and a) X-irradiation group: mast cell 
permeation is evident. (B and b) arbutin+ X-irradiation group: 
mast cell mucus is mild to moderate. (C and c) Vehicle group: 
alveolar space, bronchiole, and vascular bed are normal.        
(D and d) Control group: Alveolar space, bronchiole, and 
vascular bed are normal.  
 Control Vehicle X-irradiation arbutin + X-irradiation 
Inflammation 1.2 ±0.44 1.4±0.54 3 ±0.71 a 2.2±0.83 
Macrophage 1.4±0.54 1.4± 0.54 2.8±0.44 ac 2 ±0.71 b 
Mast cell 1.4±0.54 1.8±0.44 2.4±0.54 2.1±0.54 
Fibrosis 1.4±0.54 1.4±0.54 3.6±0.54 ac 2.8±0.83 abc 
Lymphocyte 1.4±0.54 1.4±0.54 2.2±0.83 2.2±1.09 
Erythrocyte 2±0.71 1.6±0.54 3.2±0.83 ac 2.2±0.44 b 
Neutrophil 1.2±0.44 1.4±0.54 2.4±0.54 2.2±0.54 
Values are expressed as mean±SD. P<0.05, statistically significant when compared between 
groups versus a control group, or b X-irradiation group, c Vehicle group. SD: Standard deviation. 
Figure 3. Macroscopic images of late 
pulmonary damage: A Control group: 
The lung is completely normal. B Vehicle 
group: The lung is completely normal. C 
X-irradiation group: The severe fibrosis 
represents as brown beads in the image 
(flash tip). D arbutin+ X-irradiation 
group: The mild to moderate fibrosis 
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DISCUSSION 
In the present study, rats were irradiated 
with a single dose of 20 Gy X-radiation alone or 
in the presence of arbutin to induce lung injury, 
and the effect of arbutin on radiation-induced 
lung injury was explored. The pathological 
changes occurs immediately after irradiation, 
but the clinical manifestations of radiation                
toxicity may not become apparent for weeks, 
months, or even years after radiation exposure. 
Regarding the lung, radiation-induced                        
histopathological changes manifest at least 6 
weeks after radiotherapy (16). Accordingly, we 
investigated acute radiation-induced lung injury 
in 2 and 3 months after X-irradiation. Previous 
study showed that lung lesions were more                
predominant in the high doses (17). As shown in 
table 2 and 3, in a single dose of 20 Gy X-rays, we 
observed inflammation, fibrosis, etc.   
In our study, the rats were irradiated with a 
single radiation dose of 20 Gy, and symptoms of 
decreased appetite and drinking water, and               
reduced physical activity such as movement and 
body cleaning were seen in them. In 20 days  
follow-up, we observed a significant reduction in 
body weight of X-irradiation and arbutin +                   
X-irradiation groups in comparison with                 
baseline body weights. These symptoms are 
very important because it can be a significant 
side effect of radiation exposure, that has a            
negative impact on absorption of food, and can 
lead to fatigue and weakness in patients after 
radiotherapy, and these effects reduce the                
likelihood of treatment, survival, and quality of 
life (18).  
As shown in table 2 and 3, radiation exposure 
increased the number of macrophages,                     
neutrophils, lymph nodes and other                         
inflammatory cells, as well as formation of              
collagen strands, resulting in inflammation 8 
weeks after irradiation and fibrosis 3 months 
after radiation exposure. The administration of 
arbutin as IP injection 2 hours before                    
irradiation, resulted in a reduction of                      
inflammation and fibrosis, respectively, as               
displayed in figure 1, 2, and 4. Our data                
demonstrated that arbutin significantly reduced 
radiation-induced lung damages. The results 
from our study show that arbutin can be used to 
reduce acute inflammatory pathways induced by 
radiation exposure. Also, several reports have 
been suggested different types of biological             
radioprotectors such as probiotic and other  
bacterial-based radioprotectors for daily clinical 
applications (19). The previous chemical                    
radioprotectors may be replaced by biological 
radioprotectors in order to increase therapeutic 
outcome and reduce side effects associated with 
chemical radioprotectors.  
Radiation-induced pulmonary fibrosis is           
considered as one of the common side effects 
after breast or lung cancer radiotherapy (4, 5). 
Released cytokines from macrophages that are 
activated in inflammatory process stimulate 
proliferation of fibroblasts and production of 
collagen. Also, macrophages release                   
Figure 4. Histopathologic examination of radiation damage in 
3 months after irradiation. Masson Trichrome stain with a 
magnification of × 100 (capital letters) and × 400 (lower case 
letters). Collagen sediment is shown in blue (A and a)                     
X-irradiation group:  Collagen fiber deposition is evident.           
(B and b) arbutin+ X-irradiation group: Collagen tissue               
deposition is observed moderately. (C and c) Vehicle group: 
alveolar space, bronchiole, and vascular bed are normal. (D 
and d) Control group: Alveolar space, bronchiole, and            
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anti-inflammatory cytokines including IL-4,              
IL-10, IL-13 and TGF-β that promote fibrosis (20, 
21). Mast cells help to penetrate inflammatory 
cells of alveolar inflammation by releasing                 
enzymes and active amines that are rich in         
granules through vascular periosteum (22).  
Studies have shown that mast cells have a 
critical role in fibrosis (23). Animal studies have 
been demonstrated the increased number of 
mast cells and neutrophils in the                                
radiation-induced pulmonary fibrosis (24). In  
addition, migration of inflammatory monocytes 
(bone marrow-derived inflammatory monocyte) 
into the lungs occurs after radiotherapy. A             
recent study by Groves et al. showed that CCR2+ 
infiltrating monocyte-derived macrophages had 
a great role in the development of                             
radiation-induced pulmonary fibrosis (25). Based 
on the results from our study, the number of 
mast cells, neutrophils, and macrophages were 
increased after X-irradiation. As shown in table 
2 and 3, we observed a reduction in the number 
of mast cells, neutrophils, and macrophages in 
rats that were irradiated with a single dose of 20 
Gy of X-ray 2 hours after IP injection of arbutin. 
Therefore, we propose that arbutin might be a 
potential lung radioprotector. Moreover,                
Radioprotective effects of arbutin on rat bone 
and human lymphoma U937 cells were explored 
(7, 26, 27). The frequencies of micronuclei in 1000 
polychromatic erythrocyte were significantly 
reduced using administration of arbutin before 
irradiation in mice bone marrow compared to 
control group (26). Arbutin can reduce                        
intracellular hydroxyl radical production, and 
Bax-mitochondrial pathway including JNK/p38 
MAPK activation in U937 cells, and therefore 





This study showed that arbutin improves 
symptoms of inflammation by reducing                
accumulation of macrophages. From our data, it 
can be concluded that arbutin can reduce the 
risk of radiation-induced lung injury in rat and 
acts as a lung radioprotector.  Further in-vitro 
and in-vivo studies are required to approve this 
effect and elucidate signaling pathways involved 
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